-
Q&A
A Rare DriveChordoma survivor Josh Sommer brings together researchers and patients to develop better treatments for an uncommon cancer.
by Kate Yandell
-
Treatment Is WaitingFor patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
-
Forward Look
Cancer Centers Unite to Increase HPV Vaccination RatesJoint statement recommends girls and boys be vaccinated before age 13.
by Cameron Walker
-
Forward Look
PET Scan OveruseStudy suggests lung and esophageal cancer survivors receive too many costly scans.
by Kendall K. Morgan
-
Forward Look
A Report Card on Active SurveillanceMany men with untreated prostate cancer are not getting proper follow-up.
by Heather Stringer
-
Survivor Profile
In Support and ServiceRetired Army colonel and prostate cancer survivor Jim Williams asks men to pay better attention to their health.
by Lauren Gravitz
-
Q&A
Learning Emotional JudoPsychiatrist Andrew Roth helps prostate cancer patients identify and take control of their emotions.
by Kate Yandell
-
Forward Look
Getting to the Root of Brain CancerQ&A with neurosurgeon Peter Dirks on stem cells and brain cancer.
by Chris Palmer
-
Forward Look
Breast Cancer Survivors and Vaginal EstrogenExpert opinion affirms need to weigh risks and benefits.
by Kate Yandell
-
Yesterday & Today
A Kind and Decent ManWhether playing Franklin D. Roosevelt or Richard Gilmore, the wealthy scion in 'Gilmore Girls,' Edward Herrmann took on gentlemanly roles that mirrored his real-life persona. He died of brain cancer in 2014.
by Marilyn Fenichel
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
